iPath Pure Beta Sugar ETN
SGAR
SGAR was delisted on the 11th of April, 2018.
2 hedge funds and large institutions have $15K invested in iPath Pure Beta Sugar ETN in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
69% less capital invested
Capital invested by funds: $49K → $15K (-$34K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$35.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $11K | -$35.9K | -1,105 | -79% |
|
|
NC
2
NewSquare Capital
Newtown Square,
Pennsylvania
| $4K | – | – | – |
|
SGAR Hedge Fund Activity: Q3 2016 in Review
2 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Sugar ETN (SGAR) for Q3 2016, worth a combined $15K — down 69% from $49K a quarter earlier.
Fund positioning in SGAR was balanced in Q3 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $35.9K.
- 2 institutional investors held iPath Pure Beta Sugar ETN (SGAR) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $15K of iPath Pure Beta Sugar ETN stock for Q3 2016, down 69% quarter-over-quarter.
- 0 funds opened new iPath Pure Beta Sugar ETN positions in Q3 2016 and 0 closed out.
- The largest iPath Pure Beta Sugar ETN seller in Q3 2016 was UBS Group, an estimated $35.9K sold.
Based on aggregated 13F filings for Q3 2016.